Is Centessa Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: CNTA) stock is to Hold CNTA stock.
Out of 3 analysts, 0 (0%) are recommending CNTA as a Strong Buy, 1 (33.33%) are recommending CNTA as a Buy, 1 (33.33%) are recommending CNTA as a Hold, 0 (0%) are recommending CNTA as a Sell, and 1 (33.33%) are recommending CNTA as a Strong Sell.
What is CNTA's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: CNTA) forecast ROE is N/A, which is considered weak.
What is CNTA's Price Target?
According to 3 Wall Street analysts that have issued a 1 year CNTA price target, the average CNTA price target is $4.83, with the highest CNTA stock price forecast at $6.00 and the lowest CNTA stock price forecast at $4.00.
On average, Wall Street analysts predict that Centessa Pharmaceuticals's share price could reach $4.83 by May 15, 2024. The average Centessa Pharmaceuticals stock price prediction forecasts a potential upside of 7.4% from the current CNTA share price of $4.50.
What is CNTA's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: CNTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.